Featured Jobs
|
Merkley Retirement Consultants
|
|
Distributions Processor - Qualified Retirement Plans Anchor 3(16) Fiduciary Solutions, LLC
|
|
Defined Benefit Specialist II or III Nova 401(k) Associates
|
|
EPIC RPS
|
|
Nova 401(k) Associates
|
|
Retirement Combo Plan Administrator Heritage Pension Advisors, Inc.
|
|
Compensation Strategies Group, Ltd.
|
|
BPAS
|
|
BPAS
|
|
July Business Services
|
|
The Pension Source
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Press Releases by Date | Press Releases by Company Name
View More Press Releases by Cohen Milstein Sellers & Toll PLLC
|
Press Release Dan Sutter Named ERISA Associate to Watch Out for by Chambers USA 2024 Chambers Usa |
|
Issued by Cohen Milstein Sellers & Toll PLLC June 13, 2024 |
|
Chambers USA Guide to America’s Leading Lawyers for Business (2024) has named Dan Sutter an Associate to Watch Out For in ERISA Litigation: Plaintiffs – Nationwide. Here’s what Chambers USA says: Associate Daniel Sutter regularly assists with the representation of plaintiffs in breach of fiduciary duty and other ERISA claims. In addition, Chambers USA ranked Cohen Milstein’s Employee Benefits/ERISA practice one of the top practices in the nation. Band 1 – ERISA Litigation: Plaintiff – Nationwide Cohen Milstein Sellers & Toll PLLC is highly regarded for its representation of plaintiffs in ERISA class actions. The firm is regularly sought out to represent plan participants and beneficiaries in a range of ERISA claims including breach of fiduciary duty. “Cohen Milstein are first rate. Their lawyers understand the bigger picture of cases and I enjoy working with them.” Cohen Milstein Sellers & Toll PLLC successfully represented the participants and beneficiaries of the Wells Fargo 401(k) plan in an ERISA class action lawsuit, achieving a $32.4 million settlement. |
View More Press Releases by Cohen Milstein Sellers & Toll PLLC
|
Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink. |